These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2999647

  • 1. Immunosuppressive treatment of multiple sclerosis.
    Hadaway LC.
    NITA; 1985; 8(6):503-5. PubMed ID: 2999647
    [No Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
    Neretin VIa, Kir'iakov VA, Sapfirova VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):119-26. PubMed ID: 2160156
    [No Abstract] [Full Text] [Related]

  • 3. [Pathogenesis and treatment of multiple sclerosis. Review and personal results].
    Gérard JM, Hildebrand J, Mavroudakis N, Monseu G, Przedborski S, Seeldrayers P, Wautier J, Zegers de Beyl D.
    Rev Med Brux; 1988 Sep; 9(6):334-9. PubMed ID: 2845554
    [No Abstract] [Full Text] [Related]

  • 4. Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside.
    Cendrowski W.
    Acta Neurol Belg; 1973 Sep; 73(4):209-19. PubMed ID: 4770124
    [No Abstract] [Full Text] [Related]

  • 5. [Intensive immunosuppressive treatment of chronic progressive multiple sclerosis].
    Hommes OR.
    Ned Tijdschr Geneeskd; 1978 Oct 14; 122(41):1545-51. PubMed ID: 358004
    [No Abstract] [Full Text] [Related]

  • 6. [Aspects of immunosuppressive therapy of multiple sclerosis].
    Fischer W.
    Psychiatr Neurol Med Psychol Beih; 1975 Oct 14; 20-21():23-6. PubMed ID: 829627
    [Abstract] [Full Text] [Related]

  • 7. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U, Majeron M, Mascetti A.
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb 29; 96(1):163-84. PubMed ID: 4337775
    [No Abstract] [Full Text] [Related]

  • 8. Medications used in the treatment of multiple sclerosis.
    Schapiro RT.
    Phys Med Rehabil Clin N Am; 1999 May 29; 10(2):437-46, ix. PubMed ID: 10370939
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of multiple sclerosis--now and in future. The Danish Multiple Sclerosis Society and the Danish Multiple Sclerosis Group].
    Sellebjerg FT, Sørensen PS, Dansk Selskab for Forskning i Multipel Sclerose og Dansk Multipel Sclerose Gruppe.
    Ugeskr Laeger; 2007 Mar 19; 169(12):1121. PubMed ID: 17394832
    [No Abstract] [Full Text] [Related]

  • 10. Immunosuppressive treatment of multiple sclerosis.
    Hartshorn JC.
    J Neurosurg Nurs; 1984 Oct 19; 16(5):275-8. PubMed ID: 6094750
    [Abstract] [Full Text] [Related]

  • 11. Multiple sclerosis: pilot therapeutic trial of immunosuppressants.
    Cendrowski WS.
    Schweiz Arch Neurol Neurochir Psychiatr; 1969 Oct 19; 105(2):241-6. PubMed ID: 4314087
    [No Abstract] [Full Text] [Related]

  • 12. [Late results of the treatment of the chronic progressive form of multiple sclerosis by intensive immunosuppression].
    Wender M, Tokarz-Kupczyk E, Mularek O.
    Neurol Neurochir Pol; 1989 Oct 19; 23(3):188-92. PubMed ID: 2561379
    [Abstract] [Full Text] [Related]

  • 13. [Critical opinions on the treatment of multiple sclerosis with immunosuppressive agents].
    Skłodowski P.
    Neurol Neurochir Pol; 1993 Oct 19; 27(6):877-83. PubMed ID: 8164783
    [Abstract] [Full Text] [Related]

  • 14. [Immunosuppressive medication in multiple sclerosis].
    García Merino JA.
    Rev Neurol; 1993 Oct 19; 35(12):1154-8. PubMed ID: 12497298
    [Abstract] [Full Text] [Related]

  • 15. Proceedings: Intensive immunosuppression in multiple sclerosis.
    Lance EM, Abbosh J, Kremer M, Jones V, Knight S, Medawar P.
    Neurology; 1975 May 19; 25(5):491. PubMed ID: 1169713
    [No Abstract] [Full Text] [Related]

  • 16. [Immunosuppressive treatment in neurological disorders].
    Aarli JA.
    Tidsskr Nor Laegeforen; 1973 Jun 30; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract] [Full Text] [Related]

  • 17. [Immunosuppressive therapy of multiple sclerosis using cyclophosphamide with few side effects].
    Kornhuber HH, Mauch E.
    Dtsch Med Wochenschr; 1986 Nov 14; 111(46):1778. PubMed ID: 3780443
    [No Abstract] [Full Text] [Related]

  • 18. [Initial experiences with the Reiber 1979 determination of autochthonous IgG production within the scope of clinical and immunologic follow-up studies in multiple sclerosis treated with immunosuppressive therapy].
    Dachsel R, Köppel C.
    Psychiatr Neurol Med Psychol (Leipz); 1989 Jul 14; 41(7):420-5. PubMed ID: 2772076
    [Abstract] [Full Text] [Related]

  • 19. [Present possibilities in the therapy of multiple sclerosis].
    Jedlicka P.
    Cesk Neurol Neurochir; 1987 Jul 14; 50(4):209-17. PubMed ID: 2822262
    [No Abstract] [Full Text] [Related]

  • 20. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH.
    Curr Med Res Opin; 2007 Jun 14; 23(6):1199-208. PubMed ID: 17559719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.